Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The only published dosing protocol is from mouse studies: 5 mg/kg by intraperitoneal injection, given intermittently over weeks
Any side effects experienced will usually go away within a few hours
The inhibitory ability of the designed peptide (CAND) was then verified using FPA competition analysis to ensure its continued effectiveness in inhibiting the interaction between FOXO4 and p53 TAD (Figure
Most protocols are prescribed as subcutaneous injections you can do at home (we teach you exactly how), following a schedule your provider recommends
PubMed laboratory research record [PMID: 5160358] PubMed record related to this compound for laboratory literature review
Not approved for human or animal consumption, medical treatment, or therapeutic use.
